[Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence].

La disfunzione ventricolare non ischemica nei pazienti con COVID-19: caratteristiche e implicazioni per l’imaging cardiaco in base alle attuali evidenze scientifiche.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Oct 2020
Historique:
entrez: 24 9 2020
pubmed: 25 9 2020
medline: 2 10 2020
Statut: ppublish

Résumé

Coronavirus 2019 disease (COVID-19), caused by SARS-CoV-2, can lead to cardiac impairment with various types of clinical manifestations, including heart failure and cardiogenic shock. A possible expression of cardiac impairment is non-ischemic ventricular dysfunction, which can be related to different pathological conditions, such as myocarditis, stress and cytokine-related ventricular dysfunction. The diagnosis of these pathological conditions can be challenging during COVID-19; furthermore, their prevalence and prognostic significance have not been elucidated yet. The purpose of this review is to take stock of the various aspects of non-ischemic ventricular dysfunction that may occur during COVID-19 and of the diagnostic implications related to the use of cardiac imaging techniques.

Identifiants

pubmed: 32968306
doi: 10.1714/3431.34196
doi:

Substances chimiques

Troponin 0

Types de publication

Journal Article Review

Langues

ita

Sous-ensembles de citation

IM

Pagination

739-749

Auteurs

Donato Mele (D)

U.O.C. Cardiologia, Azienda Ospedaliero-Universitaria, Ferrara.

Antonello D'Andrea (A)

U.O.C. Cardiologia/UTIC/Emodinamica, P.O. Umberto I, Nocera Inferiore (ASL Salerno), Università degli Studi della Campania "Luigi Vanvitelli".

Marco Campana (M)

U.O.C. Cardiologia, Fondazione Poliambulanza, Brescia.

Giovanna Di Giannuario (G)

U.O.C. Cardiologia, Ospedale Infermi, Rimini.

Filippo Flamigni (F)

U.O.C. Cardiologia, Azienda Ospedaliero-Universitaria, Ferrara.

Alessia Gimelli (A)

Fondazione CNR/Regione Toscana "Gabriele Monasterio", Pisa.

Georgette Khoury (G)

U.O.C. Cardiologia, Azienda Ospedaliera Santa Maria, Terni.

Massimiliano Rizzo (M)

U.O.C. Cardiologia, Ospedale San Paolo, Civitavecchia, ASL Roma 4.

Antonella Moreo (A)

Dipartimento CardioToracoVascolare "De Gasperis", ASST Grande Ospedale Metropolitano Niguarda, Milano.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH